INVESTMENT INSIGHTS
The US healthcare industry is on the cusp of significant growth, driven by a burgeoning and aging population of over 340 million, alongside regulatory tailwinds and technological advancements.
INVESTMENT INSIGHTS
Increased Outsourcing and Offshoring to Tackle Labor Shortages
Surge in Healthcare Consolidation
28%
of announced M&A deals cited financial distress as a factor in 2023, a notable increase from the 15% reported in 2022, per Kaufman Hall.
10.8% CAGR
The US Hospital Outsourcing market is estimated to grow at a CAGR of 10.8%, reaching $351.64 billion by 2032 from $126.67 billion in 2022, according to Precedence Research.
Increased Investment in Outpatient Services
16.9% Growth
The Centers for Medicare & Medical Services projects a substantial 16.9% growth in the demand for outpatient services among individuals aged 55 and above by 2025.
Rising Demand for Weight-loss Drugs
$105 billion
The global GLP-1 market is projected to grow from $36.6 billion in 2023 to $105 billion by 2029, achieving a CAGR of 19.2%
Transition from Fee-for-Service Model to Value-based Model
100%
The Centers for Medicare & Medical Services has set a goal to establish a value-based care relationship for 100% of traditional Medicare beneficiaries by the year 2030.
Increased Outsourcing and Offshoring to Tackle Labor Shortages
28%
of announced M&A deals cited financial distress as a factor in 2023, a notable increase from the 15% reported in 2022, per Kaufman Hall.
Surge in Healthcare Consolidation
10.8% CAGR
The US Hospital Outsourcing market is estimated to grow at a CAGR of 10.8%, reaching $351.64 billion by 2032 from $126.67 billion in 2022, according to Precedence Research.
Increased Investment in Outpatient Services
16.9% Growth
The Centers for Medicare & Medical Services projects a substantial 16.9% growth in the demand for outpatient services among individuals aged 55 and above by 2025.
Rising Demand for Weight-loss Drugs
$105 Billion
The global GLP-1 market is projected to grow from $36.6 billion in 2023 to $105 billion by 2029, achieving a CAGR of 19.2%
Transition from Fee-for-Service Model to Value-based Model
100%
The Centers for Medicare & Medical Services has set a goal to establish a value-based care relationship for 100% of traditional Medicare beneficiaries by the year 2030.
North America hosted the highest value of healthcare buyout deals in 2023, according to Bain & Company.
VC investors are favoring early-stage deals, resulting in smaller investment amounts spread across a larger number of companies, according to Silicon Valley Bank.
Among the healthcare sector, pharmaceuticals, drug development, and pharmaceutical distribution outperformed over the past three years.
The Healthcare sector witnessed a deal volume of 581 deals in 2024 so far, and a total disclosed deal value of $88 billion.
North America hosted the highest value of healthcare buyout deals in 2023, according to Bain & Company.
VC investors are favoring early-stage deals, resulting in smaller investment amounts spread across a larger number of companies, according to Silicon Valley Bank.
Among the healthcare sector, pharmaceuticals, drug development, and pharmaceutical distribution outperformed over the past three years.
The Healthcare sector witnessed a deal volume of 581 deals in 2024 so far, and a total disclosed deal value of $88 billion.
To know more about our
Healthcare Research and Analytics Solutions
About Us
SG Analytics’ Investment Insights segment is a premier global provider of investment research and financial analysis services, dedicated to helping clients make informed, strategic decisions in complex financial markets. We offer comprehensive research services, including equity research, fixed income and credit research, hedge fund support, and private banking support. Our team of experienced analysts delivers in-depth insights and tailored solutions that cater to the unique needs of both buy-side and sell-side firms.
By leveraging advanced technology and a client-centric approach, we enhance portfolio performance and ensure compliance with industry regulations. Our commitment to quality and precision positions us as a trusted partner in the financial research industry.
About Us
SG Analytics’ Investment Insights segment is a premier global provider of investment research and financial analysis services, dedicated to helping clients make informed, strategic decisions in complex financial markets. We offer comprehensive research services, including equity research, fixed income and credit research, hedge fund support, and private banking support. Our team of experienced analysts delivers in-depth insights and tailored solutions that cater to the unique needs of both buy-side and sell-side firms.
By leveraging advanced technology and a client-centric approach, we enhance portfolio performance and ensure compliance with industry regulations. Our commitment to quality and precision positions us as a trusted partner in the financial research industry.
SGA offers automation-powered, differentiated, and decision-oriented investment research support across sectors, asset classes, and regions for buy-side and sell-side.
SGA offers automation-powered, differentiated, and decision-oriented investment research support across sectors, asset classes, and regions for buy-side and sell-side.
Our investment banking team brings wide deal experience, deep domain expertise and extreme customer orientation to deliver comprehensive research and analytical support.
Our investment banking team brings wide deal experience, deep domain expertise and extreme customer orientation to deliver comprehensive research and analytical support.
As one of the most distinguished investment research outsourcing firms, we offer bespoke studies in equity, fixed income, currency, and commodities markets.
As one of the most distinguished investment research outsourcing firms, we offer bespoke studies in equity, fixed income, currency, and commodities markets.
